Document is current
Any future updates will be listed below
-
Authors
Liang, Nuanyi
Nho, Kwangsik
Newman, John W.
Arnold, Matthias
Huynh, Kevin
Meikle, Peter J.
Borkowski, Kamil
Kaddurah-Daouk, Rima
,
Kueider-Paisley, Alexandra
Doraiswamy, P. Murali
Blach, Colette
Moseley, Arthur
Mahmoudiandehkhordi, Siamak
Welsh-Balmer, Kathleen
Plassman, Brenda
Saykin, Andrew
Risacher, Shannon
Kastenmüller, Gabi
Han, Xianlin
Baillie, Rebecca
Knight, Rob
Dorrestein, Pieter
Brewer, James
Mayer, Emeran
Labus, Jennifer
Baldi, Pierre
Gupta, Arpana
Fiehn, Oliver
Barupal, Dinesh
Meikle, Peter
Mazmanian, Sarkis
Rader, Dan
Shaw, Leslie
van Duijin, Cornelia
Amin, Najaf
Nevado-Holgado, Alejo
Bennett, David
Krishnan, Ranga
Keshavarzian, Ali
Vogt, Robin
Ikram, Arfan
Hankemeier, Thomas
Thiele, Ines
Funk, Cory
Baloni, Priyanka
Jia, Wei
Wishart, David
Brinton, Roberta
Farrer, Lindsay
Au, Rhoda
Qiu, Wendy
Würtz, Peter
Koal, Therese
Greenwood, Anna
Krumsiek, Jan
Suhre, Karsten
Newman, John
Hernandez, Ivan
Foroud, Tatania
Sacks, Frank
-
Funding
Funding for this research was provided by:
National Institutes of Health (U01 AG072177)
National Institutes of Health (P30AG072972)
National Institutes of Health (R01 LM012535)
National Institutes of Health (U19AG074879)
United States Department of Agriculture (Project 2032-51530-025-00D)
National Health and Medical Research Council of Australia (2009965)
National Institute on Aging (NIA R01AG046171)
National Institute on Aging (RF1AG051550)
National Institute on Aging (RF1AG057452)
National Institute on Aging (R01AG059093)
National Institute on Aging (RF1AG058942)
National Institute on Aging (U01AG061359)
National Institute on Aging (U19AG063744)
National Institute on Aging (3U19AG063744-04S1)
National Institute on Aging (1R01AG081322)
National Institute on Aging (FNIH: #DAOU16AMPA)
- License Information
-
More Information
Article History
Received: 1 February 2024
Accepted: 9 July 2024
First Online: 29 July 2024
Competing interests
: Dr. Rima Kaddurah-Daouk and Dr. Matthias Arnold participated in the invention of several patents on applying metabolomics to diagnose and treat CNS diseases. Dr. Kaddurah-Daouk holds equity in Metabolon Inc., Chymia LLC and PsyProtix, which were not involved in the current study. Dr. Arnold holds equity in Chymia LLC and IP in PsyProtix. All other authors declare that they have no competing interests.
